Intracytoplasmic morphologically selected sperm injection, but for whom?

Area of Science:

• Reproductive Medicine
• Assisted Reproductive Technologies
• Sperm Morphology Analysis

Background:

• Standard Intracytoplasmic Sperm Injection (ICSI) uses limited magnification, hindering optimal sperm selection.
• Distinguishing healthy sperm morphology is challenging under routine microscopy (×400).
• High-powered optics enable ultra-high magnification (×10,160) for detailed sperm evaluation.

Purpose of the Study:

• To assess the effectiveness of Intracytoplasmic Morphologically Selected Sperm Injection (IMSI) in various infertility patient groups.
• To compare IMSI outcomes against standard ICSI in selected patient populations.
• To identify patient groups most likely to benefit from IMSI.

Main Methods:

• Comparison of routine ICSI versus IMSI across three patient groups: non-selected, male infertility, and repeated implantation failure.
• Evaluation of key outcome measures including fertilization, embryo quality, and pregnancy rates.
• Analysis of IMSI's impact on different infertility indications.

Main Results:

• IMSI significantly increased fertilization and top-quality embryo rates in the male infertility group.
• IMSI led to significant improvements in fertilization and pregnancy rates for the repeated implantation failure group.
• No significant effect of IMSI was observed in the non-selected patient group.

Conclusions:

• Intracytoplasmic Morphologically Selected Sperm Injection (IMSI) demonstrates significant benefits for specific patient cohorts.
• IMSI is particularly advantageous for patients experiencing male factor infertility and repeated implantation failures.
• The study confirms IMSI's efficacy in selected infertility cases, enhancing treatment outcomes.